Glutamine signaling specifically activates c-Myc and Mcl-1 to facilitate cancer cell proliferation and survival

Abstract

Glutamine provides carbon and nitrogen to support the proliferation of cancer cells. However, the precise reason why cancer cells are particularly dependent on glutamine remains unclear. In this study, we report that glutamine modulates the tumor suppressor F-box and WD repeat domain-containing 7 (FBW7) to promote cancer cell proliferation and survival. Specifically, lysine 604 (K604) in the sixth of the 7 substrate-recruiting WD repeats of FBW7 undergoes glutaminylation (Gln-K604) by glutaminyl tRNA synthetase. Gln-K604 inhibits SCF^FBW7-mediated degradation of c-Myc and Mcl-1, enhances glutamine utilization, and stimulates nucleotide and DNA biosynthesis through the activation of c-Myc. Additionally, Gln-K604 promotes resistance to apoptosis by activating Mcl-1. In contrast, SIRT1 deglutaminylates Gln-K604, thereby reversing its effects. Cancer cells lacking Gln-K604 exhibit overexpression of c-Myc and Mcl-1 and display resistance to chemotherapy-induced apoptosis. Silencing both c-MYC and MCL-1 in these cells sensitizes them to chemotherapy. These findings indicate that the glutamine-mediated signal via Gln-K604 is a key driver of cancer progression and suggest potential strategies for targeted cancer therapies based on varying Gln-K604 status.

Keywords

glutamine / FBW7 / c-Myc / Mcl-1 / glutamylation / QARS

References

[1] Ahluwalia GS , Grem JL , Hao Z et al. Metabolism and action of amino-acid analog anticancer agents. Pharmacol Ther 1990; 46: 243- 271.

[2] Ang XLL , Harper JW . SCF-mediated protein degradation and cell cycle control. Oncogene 2005; 24: 2860- 2870.

[3] Apraiz A , Mitxelena J , Zubiaga A . Studying cell cycleregulated gene expression by two complementary cell synchronization protocols. J Vis Exp 2017: 55745.

[4] Cangelosi AL , Puszynska AM , Roberts JM et al. Zonated leucine sensing by Sestrin-mTORC1 in the liver controls the response to dietary leucine. Science 2022; 377: 47- 56.

[5] Carr EL , Kelman A , Wu GS et al. Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T Lymphocyte activation. J Immunol 2010; 185: 1037- 1044.

[6] Chantranupong L , Scaria SM , Saxton RA et al. The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell 2016; 165: 153- 164.

[7] Cluntun AA , Lukey MJ , Cerione RA et al. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer 2017; 3: 169- 180.

[8] D'hulst G , Soro-Arnaiz I , Masschelein E et al. PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase. Nat Commun 2020; 11: 174.

[9] Dang CV , Resar LMS , Emison E et al. Function of the c-Myc oncogenic transcription factor. Exp Cell Res 1999; 253: 63- 77.

[10] Deng CX . SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 2009; 5: 147- 152.

[11] Ding XW , Huang TL , Peng CY et al. Therapeutic rationale to target highly expressed Aurora kinase a conferring poor prognosis in cholangiocarcinoma. J Cancer 2020; 11: 2241- 2251.

[12] Gaglio D , Soldati C , Vanoni M et al. Glutamine deprivation induces abortive S-phase rescued by deoxyribonucleotides in K-Ras transformed fibroblasts. PLoS One 2009; 4: e4715.

[13] Gao P , Tchernyshyov I , Chang TC et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762- 765.

[14] Harley ME , Allan LA , Sanderson HS et al. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J 2010; 29: 2407- 2420.

[15] He XD , Gong W , Zhang JN et al. Sensing and transmitting intracellular amino acid signals through reversible lysine aminoacylations. Cell Metab 2018; 27: 151- 166.e6.

[16] Inuzuka H , Shaik S , Onoyama I et al. SCF^FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011; 471: 104- 109.

[17] Jardim DL , Wheler JJ , Hess K et al. FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. PLoS One 2014; 9: e89388.

[18] Jeung YJ , Kim HG , Ahn J et al. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300. Biochim Biophys Acta 2016; 1863: 2584- 2593.

[19] Jung W , Hong KD , Jung WY et al. SIRT1 expression is associated with good prognosis in colorectal cancer. Korean J Pathol 2013; 47: 332- 339.

[20] Ko YG , Kim EK , Kim T et al. Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J Biol Chem 2001; 276: 6030- 6036.

[21] Kondo M , Yamaoka T , Honda S et al. The rate of cell growth is regulated by purine biosynthesis via ATP production and G₁ to S phase transition. J Biochem 2000; 128: 57- 64.

[22] Lau AW , Inuzuka H , Fukushima H et al. Regulation of APC^Cdh1 E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7. Cell Res 2013; 23: 947- 961.

[23] Le A , Lane AN , Hamaker M et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 2012; 15: 110- 121.

[24] Liu X , Zhao H , Jin Q et al. Resveratrol induces apoptosis and inhibits adipogenesis by stimulating the SIRT1-AMPKalpha-FOXO1 signalling pathway in bovine intramuscular adipocytes. Mol Cell Biochem 2018; 439: 213- 223.

[25] Loftus RM , Assmann N , Kedia-Mehta N et al. Amino aciddependent cMyc expression is essential for NK cell metabolic and functional responses in mice. Nat Commun 2018; 9: 2341.

[26] Lukey MJ , Greene KS , Erickson JW et al. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy. Nat Commun 2016; 7: 11321.

[27] Mao Y , Zhang J , Zhou Q et al. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation. Cell Res 2024; 34: 13- 30.

[28] Mei X , Qi D , Zhang T et al. Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defects. EMBO Mol Med 2020; 12: e9469.

[29] Meng M , Chen S , Lao T et al. Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle 2010; 9: 3921- 3932.

[30] Noguchi A , Li X , Kubota A et al. SIRT1 expression is associated with good prognosis for head and neck squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: 385- 392.

[31] Panda S , Banerjee N , Chatterjee S . Solute carrier proteins and c-Myc: a strong connection in cancer progression. Drug Discov Today 2020; 25: 891- 900.

[32] Pucci B , Kasten M , Giordano A . Cell cycle and apoptosis. Neoplasia 2000; 2: 291- 299.

[33] Saqcena M , Mukhopadhyay S , Hosny C et al. Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs. Oncogene 2015; 34: 2672- 2680.

[34] Thompson CB . Rethinking the regulation of cellular metabolism. Cold Spring Harb Symp Quant Biol 2011; 76: 23- 29.

[35] Vardhana SA , Arnold PK , Rosen BP et al. Glutamine independence is a selectable feature of pluripotent stem cells. Nat Metab 2019; 1: 676- 687.

[36] Vo M-N , Terrey M , Lee JW et al. ANKRD16 prevents neuron loss caused by an editing-defective tRNA synthetase. Nature 2018a; 557: 510- 515.

[37] Vo M-N , Terrey M , Lee JW et al. Publisher Correction: ANKRD16 prevents neuron loss caused by an editing-defective tRNA synthetase. Nature 2018b; 560: E35.

[38] Wang F , Li H , Yan XG et al. Alisertib induces cell cycle arrest and autophagy and suppresses epithelialto-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin I-mediated signaling pathways in human pancreatic cancer cells. Drug Design Dev Ther 2015; 9: 575- 601.

[39] Wei CY , Bajpai R , Hunter AD et al. Glutamine catabolism maintains MCL-1 expression in glucose-deprived multiple myeloma. Blood 2017; 130: 3076.

[40] Welcker M , Clurman BE . FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8: 83- 93.

[41] Winnicki K , Polit JT , Maszewski J . Increased transcription in hydroxyurea-treated root meristem cells of Vicia faba. Protoplasma 2013; 250: 251- 259.

[42] Wise DR , Thompson CB . Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010; 35: 427- 433.

[43] Wise DR , DeBerardinis RJ , Mancuso A et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 2008; 105: 18782- 18787.

[44] Yang CD , Ko B , Hensley CT et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell 2014; 56: 414- 424.

[45] Yang LF , Achreja A , Yeung TL et al. Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironmentregulated cancer cell growth. Cell Metab 2016; 24: 685- 700.

[46] Ye MX , Zhang Y , Zhang XX et al. Targeting FBW7 as a strategy to overcome resistance to targeted therapy in non-small cell lung cancer. Cancer Res 2017; 77: 3527- 3539.

[47] Yoo HC , Yu YC , Sung Y et al. Glutamine reliance in cell metabolism. Exp Mol Med 2020; 52: 1496- 1516.

[48] Zhou S , Li MT , Jia YY et al. Regulation of cell cycle regulators by SIRT1 contributes to resveratrol-mediated prevention of pulmonary arterial hypertension. Biomed Res Int 2015; 2015: 762349.

RIGHTS & PERMISSIONS

The Author(s). Published by Oxford University Press on behalf of Higher Education Press.